SCHEMBL27428862

SCHEMBL27428862

Oc1nc(-c2ccccc2)n[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 7/20 0.61
NR1H3 Q13133 7/20 0.61
ADORA2A P29274 1/20 0.58
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
LMNA P02545 2/20 0.50
HPGDS O60760 1/20 0.50
DGAT1 O75907 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
HPGD P15428 2/20 0.49
TP53 P04637 1/20 0.49
CYP1A2 P05177 1/20 0.49
ALPL P05186 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
S1PR1 P21453 1/20 0.45
S1PR3 Q99500 1/20 0.45
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26109131 0.89 NR1H2 (0.45) NR1H2NR1H3ADORA2ANPC1RAB9A
SCHEMBL666693 0.76 NR1H2 (1.00) NR1H2NR1H3ADORA2ANPC1RAB9A
SCHEMBL17279695 0.75 NR1H2 (0.79) NR1H2NR1H3ADORA2ANPC1RAB9A
SCHEMBL3006018 0.74 NR1H2 (0.61) NR1H2NR1H3ADORA2ANPC1RAB9A
SCHEMBL1436121 0.74 NR1H2 (0.61) NR1H2NR1H3ADORA2ANPC1RAB9A
SCHEMBL1686718 0.74 NR1H2 (0.61) NR1H2NR1H3ADORA2ANPC1RAB9A
SCHEMBL657644 0.74 NR1H2 (0.61) NR1H2NR1H3ADORA2ANPC1RAB9A
SCHEMBL7067844 0.74 NR1H2 (0.61) NR1H2NR1H3ADORA2ANPC1RAB9A
SCHEMBL17574086 0.74 NR1H2 (0.96) NR1H2NR1H3ADORA2ANPC1RAB9A
SCHEMBL1071190 0.74 NR1H2 (0.96) NR1H2NR1H3ADORA2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101511360-A Compositions and methods for the treatment of mucormycosis and other fungal diseases LOS ANGELES BIOMED RES INST (US) 2009-08-19 CN disclosed
CN-1102623-C Curing process for cationically photocurable formulation CIBA SC HOLDING AG (CH) 2003-03-05 CN disclosed
CN-1225109-A Curing process for cationically photocurable formulation CIBA SC HOLDING AG (CH) 1999-08-04 CN disclosed